BlossomHill Therapeutics, Inc. Shareholders' Equity
BlossomHill Therapeutics, Inc. (BLSM) had Shareholders' Equity of -$174.78 million as of 2026-06-30, per its 10-Q filed 2026-09-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-18
- 2026-06-30: Stockholders' Equity Attributable to Parent -$174.78M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$152.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$131.73M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$96.03M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$174.78M 10-Q · filed 2026-09-18 |
| 2026-03-31 | -$152.12M 10-Q · filed 2026-09-18 |
| 2025-12-31 | -$131.73M 10-Q · filed 2026-09-18 |
| 2025-06-30 | -$96.03M 10-Q · filed 2026-09-18 |
| 2025-03-31 | -$83.09M 10-Q · filed 2026-09-18 |
| 2024-12-31 | -$72.88M 10-Q · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |